Get the Stockscreener App
1.86
0.54%
0.01
After Hours:
1.86
Esperion Therapeutics Inc Stock (ESPR) Forecast
The Esperion Therapeutics Inc (ESPR) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $21.07, representing a +1,033% increase from the current price of $1.86. The highest analyst price target is $35.84, and the lowest is $6.2955.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month ESPR Price Target
Average 17.96
(+865.45% Upside)
Is Esperion Therapeutics Inc (ESPR) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 37.11 | Neutral |
| STOCH(9,6) | 28.68 | Neutral |
| STOCHRSI(14) | 42.62 | Neutral |
| MACD(12,26) | -0.1294 | Sell |
| ADX(14) | 21.53 | Neutral |
| William %R | -72.73 | Neutral |
| CCI(14) | -44.80 | Neutral |
Buy: 0
Sell: 1
Neutral: 6
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
1.872
Sell
|
1.9037
Sell
|
| MA20 |
2.0395
Sell
|
2.0024
Sell
|
| MA50 |
2.3629
Sell
|
2.1634
Sell
|
| MA100 |
2.1955
Sell
|
2.197
Sell
|
| MA200 |
2.1953
Sell
|
2.1395
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, ESPR could be considered a Strong Sell, with 17 technical analysis indicators signaling 0 Buy signals, 11 signaling Sell signals and 6 Neutral signals. This might not be a good time to consider opening new positions on ESPR, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 37.11 indicates that ESPR is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 28.68 indicates that ESPR is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 42.62 indicates that ESPR is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 21.53 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -44.8 indicates that ESPR is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term ESPR price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Esperion Therapeutics Inc financial reports and earnings history, Esperion Therapeutics Inc (ESPR) stock could reach $44.22 by 2030, $34.80 by 2040 and $108.19 by 2050. See the projected annual prices until 2050 of the Esperion Therapeutics Inc stock below:
- Esperion Therapeutics Inc (ESPR) is expected to reach an average price of $11.44 in 2035, with a high prediction of $13.09 and a low estimate of $11.54. This indicates an $515.07% rise from the last recorded price of $1.86.
- Esperion Therapeutics Inc (ESPR) stock is projected to chart a bullish course in 2040, with an average price target of $33.70, representing an $1,712% surge from its current level. The forecast ranges from a conservative $33.90 to a sky-high $34.80.
- Our analysts predict Esperion Therapeutics Inc (ESPR) to jump 3,124% by 2045, soaring from $60.90 to an average price of $59.96, potentially reaching $61.70. While $60.90 is the low estimate, the potential upside is significant.
- Esperion Therapeutics Inc (ESPR) stock is expected to climb by 2050, reaching an average of $105.03, a $5,547% jump from its current level. However, a wide range of estimates exists, with high and low targets of $108.19 and $105.85, respectively, highlighting the market's uncertainty.
Esperion Therapeutics Inc Stock (ESPR) Year by Year Forecast
Esperion Therapeutics Inc Stock (ESPR) Price Forecast for 2025
Esperion Therapeutics Inc Stock (ESPR) is expected to reach an average price of $17.96 in 2025, with a high prediction of $35.84 and a low estimate of $0.0728. This indicates an +865.45% rise from the last recorded price of $1.86.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| March, 2025 | $8.084 | $6.2955 | $35.84 | +334.62% |
| April, 2025 | $8.5409 | $8.6422 | $16.11 | +359.19% |
| May, 2025 | $0.486 | $2.414 | $6.0941 | -73.87% |
| June, 2025 | $6.6529 | $0.0728 | $14.21 | +257.68% |
| July, 2025 | $7.4465 | $0.6564 | $10.54 | +300.35% |
| August, 2025 | $13.66 | $6.1533 | $16.35 | +634.59% |
| September, 2025 | $1.2503 | $0.3036 | $15.18 | -32.78% |
| October, 2025 | $2.034 | $1.076 | $2.444 | +9.35% |
| November, 2025 | $1.8509 | $0.1709 | $4.5474 | -0.49% |
| December, 2025 | $4.5855 | $1.0824 | $2.7862 | +146.53% |
Esperion Therapeutics Inc Stock (ESPR) Price Forecast for 2026
The predicted value for Esperion Therapeutics Inc (ESPR) in 2026 is set at an average of $7.1053. Estimates vary from a peak of $14.11 to a trough of $0.1047, indicating an +282.01% surge from the present price of $1.86.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $6.9086 | $6.3053 | $5.4586 | +271.43% |
| February, 2026 | $5.0717 | $5.1685 | $5.0069 | +172.67% |
| March, 2026 | $7.1248 | $6.235 | $3.3883 | +283.06% |
| April, 2026 | $2.3412 | $0.1047 | $7.1336 | +25.87% |
| May, 2026 | $1.8743 | $3.096 | $2.2378 | +0.77% |
| June, 2026 | $3.6874 | $2.9891 | $2.4509 | +98.25% |
| July, 2026 | $6.9738 | $3.5272 | $6.4338 | +274.94% |
| August, 2026 | $2.8569 | $8.6869 | $8.5403 | +53.60% |
| September, 2026 | $9.1733 | $5.1402 | $7.6933 | +393.19% |
| October, 2026 | $13.61 | $10.92 | $11.98 | +631.53% |
| November, 2026 | $14.17 | $13.97 | $13.19 | +661.80% |
| December, 2026 | $14.36 | $14.51 | $14.11 | +671.82% |
Esperion Therapeutics Inc Stock (ESPR) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Esperion Therapeutics Inc (ESPR) is $15.91, with a high forecast of $19.61 and a low forecast of $12.20. This indicates an +755.14% increase from the last price of $1.86.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $16.98 | $14.56 | $16.20 | +812.85% |
| February, 2027 | $17.74 | $16.54 | $16.61 | +853.87% |
| March, 2027 | $19.18 | $17.25 | $18.93 | +931.10% |
| April, 2027 | $19.81 | $19.22 | $19.32 | +965.14% |
| May, 2027 | $19.54 | $19.22 | $19.61 | +950.79% |
| June, 2027 | $18.09 | $18.30 | $19.17 | +872.64% |
| July, 2027 | $17.06 | $17.05 | $17.27 | +817.43% |
| August, 2027 | $16.30 | $16.01 | $16.55 | +776.20% |
| September, 2027 | $14.49 | $14.70 | $15.18 | +679.23% |
| October, 2027 | $14.07 | $14.42 | $14.17 | +656.28% |
| November, 2027 | $12.37 | $12.80 | $12.92 | +565.04% |
| December, 2027 | $11.56 | $12.20 | $12.30 | +521.30% |
Esperion Therapeutics Inc Stock (ESPR) Price Forecast for 2028
In 2028, Esperion Therapeutics Inc (ESPR) is projected to reach an average price of $8.87, with a high projection of $10.72 and a low estimate of $7.0226. This indicates an +376.88% rise from the last price of $1.86.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $9.7693 | $10.15 | $10.61 | +425.23% |
| February, 2028 | $10.30 | $10.12 | $9.756 | +453.89% |
| March, 2028 | $8.0888 | $8.3088 | $9.1772 | +334.88% |
| April, 2028 | $8.7319 | $8.0853 | $8.4119 | +369.46% |
| May, 2028 | $8.7383 | $8.6184 | $8.735 | +369.80% |
| June, 2028 | $7.3514 | $7.5314 | $8.3315 | +295.24% |
| July, 2028 | $7.9345 | $7.5179 | $7.4345 | +326.58% |
| August, 2028 | $8.2009 | $7.0226 | $7.4028 | +340.91% |
| September, 2028 | $10.78 | $10.74 | $10.72 | +479.78% |
| October, 2028 | $10.12 | $10.25 | $10.61 | +443.93% |
| November, 2028 | $9.3734 | $9.4584 | $9.7603 | +403.95% |
| December, 2028 | $8.7165 | $8.8165 | $9.1317 | +368.63% |
Esperion Therapeutics Inc Stock (ESPR) Price Forecast for 2029
The 2029 price forecast for Esperion Therapeutics Inc Stock (ESPR) is $22.38 on average, with a high prediction of $44.59 and a low estimate of $0.1736. This represents an +1,103% increase from the previous price of $1.86.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $7.7529 | $7.8079 | $8.3898 | +316.82% |
| February, 2029 | $7.316 | $7.401 | $7.2595 | +293.33% |
| March, 2029 | $6.6491 | $6.7891 | $6.7226 | +257.48% |
| April, 2029 | $6.6122 | $6.7329 | $6.6457 | +255.50% |
| May, 2029 | $5.7534 | $5.7936 | $6.3056 | +209.32% |
| June, 2029 | $4.5917 | $4.7617 | $5.1619 | +146.87% |
| July, 2029 | $2.4148 | $3.0648 | $4.265 | +29.83% |
| August, 2029 | $2.4812 | $2.6214 | $2.4879 | +33.40% |
| September, 2029 | $1.3843 | $1.4943 | $2.2545 | -25.57% |
| October, 2029 | $0.9207 | $1.2157 | $1.1224 | -50.50% |
| November, 2029 | $0.6338 | $0.2672 | $0.6595 | -65.93% |
| December, 2029 | $45.99 | $0.1736 | $44.59 | +2,373% |
Esperion Therapeutics Inc Stock (ESPR) Price Forecast for 2030
Esperion Therapeutics Inc Stock (ESPR) is expected to reach an average price of $35.66 in 2030, with a high forecast of $52.93 and a low forecast of $18.40. This signifies an +1,817% surge from the last price of $1.86.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $44.96 | $45.55 | $44.22 | +2,317% |
| February, 2030 | $47.61 | $45.09 | $45.65 | +2,459% |
| March, 2030 | $53.27 | $50.18 | $51.88 | +2,764% |
| April, 2030 | $54.02 | $54.18 | $52.93 | +2,804% |
| May, 2030 | $52.40 | $52.81 | $52.93 | +2,717% |
| June, 2030 | $47.99 | $49.05 | $50.34 | +2,480% |
| July, 2030 | $36.83 | $45.62 | $46.21 | +1,880% |
| August, 2030 | $31.24 | $35.67 | $33.77 | +1,579% |
| September, 2030 | $24.28 | $25.14 | $24.79 | +1,206% |
| October, 2030 | $11.81 | $18.40 | $25.78 | +534.72% |
| November, 2030 | $48.39 | $24.44 | $33.06 | +2,502% |
| December, 2030 | $49.23 | $49.19 | $45.98 | +2,547% |
0.57%
3.76%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):